Viewing Study NCT01258868


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-03-08 @ 4:27 AM
Study NCT ID: NCT01258868
Status: TERMINATED
Last Update Posted: 2019-12-03
First Post: 2010-12-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mesolthelioma View
None Esophageal Cancer View
None Lung Cancer View
None Thoracic Sarcomas View
None Thymoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mesothelioma View
None Esophageal Cancer View
None Lung Cancer View
None Thoracic Malignancies View
None Tumor Cell Vaccine View